Catalyst Wire Dossier Catalyst Wire Dossier

KLISYRI

tirbanibulin · Almirall, LLC
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for KLISYRI, covering 2020-12-14 to 2026-02-19. Get the full timeline:

Most recent: EMA Authorised: Klisyri (tirbanibulin) — Almirall, S.A.

See pricing